AHK-Cu vs AHK Copper — Same Peptide, Different Names

The most common misconception about AHK-Cu versus AHK copper is that they represent different compounds requiring a side-by-side comparison. They don't. Both terms refer to the same tripeptide-copper complex. GHK-Cu (glycyl-L-histidyl-L-lysine bound to Cu²⁺). And the naming variation exists purely because suppliers use different shorthand conventions. Our team at Real Peptides fields this question weekly from researchers who assume 'AHK' and 'GHK' represent structurally distinct molecules.

Here's what creates the confusion: some suppliers label the compound using the full amino acid sequence (GHK), while others use the single-letter abbreviation (AHK). Alanine-Histidine-Lysine. The 'copper' or 'Cu' suffix simply indicates the metal ion chelated to the peptide backbone. The biological activity, molecular weight (approximately 340 Da), and mechanism of action remain identical regardless of label.

What's the difference between AHK-Cu and AHK copper?

There is no molecular difference. AHK-Cu and AHK copper are two names for the same copper peptide complex, GHK-Cu. The terms are used interchangeably across research literature and supplier catalogs. Both refer to a tripeptide (glycyl-L-histidyl-L-lysine) chelated to a copper ion (Cu²⁺), which acts as a signalling molecule in tissue remodelling, wound healing, and collagen synthesis studies. The only distinction is nomenclature preference. Some suppliers use 'AHK' as shorthand, others use 'GHK', and 'copper' versus 'Cu' are alternate ways to denote the metal component.

The real question isn't which term is correct. It's which supplier's synthesis protocol, purity verification, and handling standards meet research-grade requirements. Every batch we produce undergoes HPLC and mass spectrometry validation to confirm the copper-peptide ratio sits within the narrow therapeutic window required for reproducible biological activity.

Why the Nomenclature Confusion Exists

The inconsistency traces back to early research publications. Loren Pickart's foundational 1973 work on wound healing identified the compound as GHK-Cu. Using the single-letter amino acid code (Glycine-Histidine-Lysine). Subsequent studies adopted this convention, and it became the standard in peer-reviewed literature. However, some commercial suppliers later abbreviated it as AHK to avoid confusion with other glycine-containing peptides in their catalogs. Creating a parallel naming system that persists in the research supply market.

Here's where it gets more confusing: neither 'AHK' nor 'GHK' is chemically incorrect, but the single-letter code varies depending on nomenclature system. In IUPAC naming, glycine is 'G', histidine is 'H', lysine is 'K'. Making GHK the accurate abbreviation. The 'A' in some supplier labels likely stems from a misapplication of three-letter amino acid codes (Ala-His-Lys), which would make the peptide start with alanine instead of glycine. A structurally different molecule with no copper-binding activity.

The copper designation adds another layer. 'Cu' is the elemental symbol from the periodic table (from Latin cuprum), while 'copper' is the English name. Some suppliers write 'GHK-Cu', others 'GHK copper', and still others 'copper peptide GHK'. All referring to the same chelated complex. The biologically active form requires the Cu²⁺ ion bound at a 1:1 molar ratio to the tripeptide; without copper, the peptide loses nearly all of its signalling capacity in fibroblast activation assays.

Our experience working with research institutions shows the naming variance causes procurement errors. Labs occasionally order 'AHK' assuming it differs from their previous 'GHK-Cu' stock, then discover they've duplicated inventory. The solution: always verify the CAS number (49557-75-7 for the copper complex) and request a certificate of analysis confirming amino acid sequencing and copper content by ICP-MS (inductively coupled plasma mass spectrometry). If those match, the name on the label is irrelevant.

What Actually Matters: Purity and Copper Ratio

The name doesn't affect biological activity. The copper-to-peptide ratio does. GHK-Cu (or AHK-Cu, if that's the label you're reading) operates through copper-dependent mechanisms that require precise metal chelation. Too little copper, and the peptide can't activate TGF-β (transforming growth factor-beta) pathways involved in extracellular matrix synthesis. Too much free copper, and you introduce cytotoxic oxidative stress that undermines the wound healing response the peptide is meant to support.

Research-grade GHK-Cu should contain 1 mole of Cu²⁺ per mole of peptide. Verified by atomic absorption spectroscopy or ICP-MS. Commercial suppliers occasionally ship formulations with copper content as low as 0.6:1 or as high as 1.4:1, either from incomplete chelation during synthesis or from copper dissociation during storage. Studies published in the Journal of Investigative Dermatology found that deviations beyond ±10% from the 1:1 ratio reduce fibroblast proliferation rates by 30–40% in vitro. A meaningful loss of experimental reliability.

Purity is the second non-negotiable. The peptide sequence itself (Gly-His-Lys) is straightforward to synthesise via solid-phase peptide synthesis (SPPS), but contamination with deletion sequences, misfolded analogs, or residual protecting groups reduces both potency and reproducibility. HPLC purity below 95% introduces uncontrolled variables into any assay measuring collagen upregulation, angiogenesis, or anti-inflammatory signalling. The three primary research applications for GHK-Cu.

We've seen researchers attribute failed experiments to 'AHK versus GHK differences' when the actual issue was a batch purity of 88% versus the 98% standard. The naming convention didn't change the outcome. The synthesis quality did. Every peptide we ship includes third-party verification of both sequence (confirmed by MALDI-TOF mass spectrometry) and copper content, so the label becomes a non-issue once the data is verified.

Storage conditions matter as much as initial purity. Lyophilised GHK-Cu is stable at −20°C for 24+ months, but once reconstituted in sterile water or saline, the copper-peptide complex begins to dissociate at a rate dependent on pH and temperature. At neutral pH (7.0–7.4) and refrigeration (2–8°C), the compound remains stable for approximately 4–6 weeks. Above 8°C or below pH 6.5, copper dissociation accelerates. Reducing biological activity without any visible change in solution appearance. If your 'AHK copper' stock has been stored improperly, it doesn't matter what the label says. It won't perform.

AHK-Cu vs AHK Copper: Research Applications Comparison

Before placing an order, verify what you're actually comparing. The table below clarifies the key attributes researchers should confirm. Not between 'AHK' and 'GHK' (which are identical), but between suppliers offering the same compound under different names.

The bottom line: if the CAS number matches and purity verification confirms ≥98% by HPLC with a 1:1 copper ratio, the name on the vial is irrelevant. Order based on data, not label.

Key Takeaways

• AHK-Cu and AHK copper are identical to GHK-Cu. All three terms refer to the same glycyl-L-histidyl-L-lysine tripeptide chelated to Cu²⁺.
• The naming inconsistency stems from supplier shorthand conventions, not from molecular differences. Always cross-reference the CAS number (49557-75-7) to confirm identity.
• Research-grade copper peptides require a 1:1 molar ratio of copper to peptide, verified by ICP-MS. Deviations beyond ±10% reduce fibroblast activation by 30–40% in published assays.
• HPLC purity below 95% introduces deletion sequences and misfolded analogs that undermine experimental reproducibility. Insist on ≥98% purity with third-party verification.
• Lyophilised GHK-Cu remains stable for 24 months at −20°C, but once reconstituted, copper dissociation begins within 4–6 weeks at refrigeration temperatures. Plan usage accordingly.
• The label means nothing if synthesis quality and handling protocols don't meet research standards. Verify batch data before assuming 'AHK' and 'GHK' perform differently.

What If: AHK-Cu / GHK Copper Scenarios

What If I Ordered AHK-Cu Instead of GHK-Cu — Did I Get the Wrong Compound?

No. You received the same molecule under a different name. Verify the CAS number on your certificate of analysis reads 49557-75-7 and confirm HPLC purity is ≥98%. If both match, the peptide is identical regardless of whether the supplier labeled it AHK-Cu, GHK-Cu, or copper peptide GHK. The functional test: reconstitute a small aliquot and confirm it dissolves to a clear, slightly blue-tinted solution. The copper ion imparts a faint color that's absent in copper-free peptides.

What If My Supplier Lists 'Copper Peptide' Without Specifying AHK or GHK?

Request the amino acid sequence and molecular weight. GHK-Cu has a molecular weight of approximately 340 Da and a sequence of Gly-His-Lys-Cu²⁺. If the supplier cannot provide sequencing data or a certificate confirming copper content by atomic absorption, the product is not research-grade. Generic 'copper peptide' labels occasionally refer to other complexes (like copper-binding domains from larger proteins) that lack the wound healing and matrix remodelling activity specific to GHK-Cu. Don't assume equivalence without data.

What If I've Been Storing Reconstituted GHK-Cu for Three Months — Is It Still Active?

Unlikely. Reconstituted GHK-Cu stored at 2–8°C begins losing copper chelation stability after 4–6 weeks, with measurable declines in fibroblast proliferation assays by week 8. If your solution is three months old, assume copper dissociation has reduced biological activity to subtherapeutic levels. The peptide backbone may still be intact (verifiable by HPLC), but without the 1:1 copper ratio, it won't activate TGF-β pathways or stimulate collagen synthesis at published rates. Discard and reconstitute fresh stock for reliable results.

What If My AHK-Cu Arrived as a Blue Powder Instead of White?

A faint blue tint is normal. It indicates copper ion presence. Pure lyophilised GHK-Cu ranges from off-white to pale blue depending on copper content and residual moisture. However, a deep or dark blue color suggests excess free copper that isn't properly chelated to the peptide, which increases oxidative stress risk in cell culture models. Request a certificate of analysis confirming the copper-to-peptide ratio by ICP-MS before using the batch in any assay where metal ion toxicity could confound results.

The Blunt Truth About AHK-Cu vs GHK Copper

Here's the honest answer: there is no AHK-Cu versus GHK copper decision to make. The entire comparison is a non-issue created by inconsistent supplier labeling. What matters is whether the peptide you're ordering. Regardless of name. Meets the molecular and purity standards required for reproducible research. A supplier selling 92% pure 'GHK-Cu' with a 0.7:1 copper ratio will give you worse results than a supplier selling 98% pure 'AHK copper' at the correct 1:1 ratio, even though the label sounds less familiar.

The peptide research community would benefit from standardised nomenclature, but until that happens, the burden falls on researchers to verify batch data instead of assuming label consistency. If you're comparing quotes between suppliers and one lists 'AHK-Cu' at a lower price than another's 'GHK copper', the name difference explains nothing. Request certificates of analysis for both and compare HPLC chromatograms, mass spec data, and copper quantification. The cheaper product might be legitimately equivalent or it might be cutting corners on synthesis quality. The label won't tell you which.

Our approach at Real Peptides: we list both names in product descriptions because researchers search using different terms, but every batch ships with the same third-party verification. MALDI-TOF for sequence confirmation, HPLC for purity (≥98%), and ICP-MS for copper content. The name on your invoice is irrelevant once the data proves molecular identity. That's the standard every supplier should meet, and the standard every researcher should demand before placing an order.

If the peptide lacks verified sequencing, confirmed copper ratio, and documented purity above 95%, it doesn't matter whether it's labeled AHK, GHK, or 'proprietary copper complex'. It's not research-grade, and results won't replicate across experiments. Name recognition means nothing. Data verification means everything.